ARCHIVES

Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds

This article is from The Cancer Letter archive.

Vol. 31 No. 11 | November 28, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Grants Priority Review To Two Drugs in NSCLC

February 22, 2013

DCT board Okays Recompetition of Clinical Trials Contracts

October 29, 1993

Neutron Therapy “Treatment Of Choice” In Salivary Gland Tumors – 100 Percent Complete Reponses

June 13, 1986

Top NCI Officials Pledge No Further Consolidation of Clinical Trials System

December 5, 2014

FDA Orders More Changes In ESA Label,

August 8, 2008

FDA Lists Therapies being Tested For AIDS, Opportunistic Infections

January 24, 1992